112 related articles for article (PubMed ID: 38925849)
1. Mast Cell-related Prognosis Signature Characterizes Immune Landscape and Predicts Prognosis of Ovarian Cancer.
Li Q; Guan T; Mao J; King BP; Johnson K; Mayberry TG; Cowan BC; Wakefield MR; Fang Y; Zhao Q
Anticancer Res; 2024 Jul; 44(7):2775-2786. PubMed ID: 38925849
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of molecular subtype and signature of immune cell-related telomeric genes and prediction of prognosis and immunotherapy efficacy in ovarian cancer patients.
Ling L; Li B; Wu H; Zhang K; Li S; Ke B; Zhu Z; Liu T; Liu P; Zhang B
J Gene Med; 2024 Jan; 26(1):e3606. PubMed ID: 38282157
[TBL] [Abstract][Full Text] [Related]
3. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
4. Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.
Liu L; Liu Q
Sci Rep; 2024 Apr; 14(1):9914. PubMed ID: 38688945
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer.
Yu D; Luo Y; Guo R; Ma F; Chang Y; Dang J
J Gene Med; 2024 May; 26(5):e3686. PubMed ID: 38689382
[TBL] [Abstract][Full Text] [Related]
6. Identifying a Novel Eight-NK Cell-related Gene Signature for Ovarian Cancer Prognosis Prediction.
Li N; Yu K; Huang D; Zhou H; Zeng D
Curr Med Chem; 2024; 31(12):1578-1594. PubMed ID: 37650393
[TBL] [Abstract][Full Text] [Related]
7. A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer.
Zhou M; Wu T; Yuan Y; Dong SJ; Zhang ZM; Wang Y; Wang J
J Ovarian Res; 2022 May; 15(1):54. PubMed ID: 35513874
[TBL] [Abstract][Full Text] [Related]
8. Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma.
Che Y; Luo Z; Zhang C; Sun N; Gao S; He J
Int Immunopharmacol; 2020 Oct; 87():106802. PubMed ID: 32745903
[TBL] [Abstract][Full Text] [Related]
9. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
11. Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes.
Ma B; Ren C; Yin Y; Zhao S; Li J; Yang H
Front Immunol; 2024; 15():1411132. PubMed ID: 38840928
[TBL] [Abstract][Full Text] [Related]
12. A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancer.
Ding Q; Dong S; Wang R; Zhang K; Wang H; Zhou X; Wang J; Wong K; Long Y; Zhu S; Wang W; Ren H; Zeng Y
Aging (Albany NY); 2020 Mar; 12(6):4879-4895. PubMed ID: 32208363
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
14. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD.
Ma C; Gu Z; Yang Y
J Cell Mol Med; 2024 Apr; 28(8):e18282. PubMed ID: 38647237
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
16. Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
An Y; Yang Q
Biomed Res Int; 2020; 2020():7594098. PubMed ID: 33381581
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
19. Development of a multi-gene-based immune prognostic signature in ovarian Cancer.
Cao T; Shen H
J Ovarian Res; 2021 Jan; 14(1):20. PubMed ID: 33509250
[TBL] [Abstract][Full Text] [Related]
20. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer.
Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z
Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
